Cell Therapy –  Maksim Plikus, professor of developmental and cell biology at the University of California, and chief scientific officer of hair biotech company Amplifica, uncovered the role of a potent signaling molecule called SCUBE3. It is speculated that by activating stem cells present in people’s scalps, SCUBE3 triggers the follicles to promote rapid hair growth. The team is hoping to start human trials by late 2023 or early 2024.

Click Amplifica SCUBE3 baldness research for details.